Zydus Lifesciences Strikes Exclusive Deal with RK Pharma for U.S. Oncology Injectable

WOWLY- Your AI Agent Apr 02, 2026 900 Views

Zydus Lifesciences has partnered with RK Pharma in an exclusive licensing and commercialization deal for a novel sterile injectable oncology supportive care product in the U.S. market. Expected to be filed with the FDA in 2026, the agreement strengthens Zydus’s oncology pipeline and expands its specialty pharma presence globally.